These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11105604)

  • 21. Hemovigilance for improvement of blood safety.
    Robillard P; Chan P; Kleinman S
    Transfus Apher Sci; 2004 Oct; 31(2):95-8. PubMed ID: 15501413
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 25. [Transfusion safety and haemovigilance committees].
    Quaranta JF; Canivet N; Courbil R; Raucoules-Aimé M
    Transfus Clin Biol; 2007 May; 14(1):107-11. PubMed ID: 17513159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How do I implement a hospital-based blood management program?
    Yazer MH; Waters JH
    Transfusion; 2012 Aug; 52(8):1640-5. PubMed ID: 22098376
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
    Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood transfusions: is "safest ever" safe enough?
    Biedrycki BA
    ONS News; 2004 Nov; 19(11):8-9. PubMed ID: 15586733
    [No Abstract]   [Full Text] [Related]  

  • 29. [Strategies and management of hospital blood center services for safety and efficacy of blood transfusion].
    Tsukimoto I; Shigeta K
    Rinsho Byori; 1991 Mar; Suppl 88():195-204. PubMed ID: 1856968
    [No Abstract]   [Full Text] [Related]  

  • 30. The French haemovigilance system.
    Debeir J; Noel L; Aullen J; Frette C; Sari F; Mai MP; Cosson A
    Vox Sang; 1999; 77(2):77-81. PubMed ID: 10516551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3d National Congress on Transfusion Safety and Hemovigilance. Lille, France, 16-7 September 1999. Proceedings and abstracts].
    Transfus Clin Biol; 2000 Feb; 7(1):5-49. PubMed ID: 10841623
    [No Abstract]   [Full Text] [Related]  

  • 33. Transfusion support of patients with sickle cell disease at the Children's Hospital of Philadelphia.
    Sesok-Pizzini DA; Friedman DF; Smith-Whitley K; Nance SJ
    Immunohematology; 2006; 22(3):121-5. PubMed ID: 17105360
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality control and transfusion reactions.
    Beal RW
    Anaesth Intensive Care; 1980 May; 8(2):172-7. PubMed ID: 6772054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Wrong blood in tube': solutions for a persistent problem.
    Ansari S; Szallasi A
    Vox Sang; 2011 Apr; 100(3):298-302. PubMed ID: 20738838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Future transfusion specialists, supervisors of quality and safety].
    Rydberg L
    Lakartidningen; 2000 Jun; 97(23):2870-5. PubMed ID: 10885225
    [No Abstract]   [Full Text] [Related]  

  • 37. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood safety in Sub-Saharan Africa: a multi-factorial problem.
    Tagny CT; Mbanya D; Tapko JB; Lefrère JJ
    Transfusion; 2008 Jun; 48(6):1256-61. PubMed ID: 18713111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.
    Brooks JP
    Transfusion; 2005 Oct; 45(4 Suppl):159S-71S. PubMed ID: 16181401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consecutive national surveys of ABO-incompatible blood transfusion in Japan.
    Fujii Y; Shibata Y; Miyata S; Inaba S; Asai T; Hoshi Y; Takamatsu J; Takahashi K; Ohto H; Juji T; Sagawa K
    Vox Sang; 2009 Oct; 97(3):240-6. PubMed ID: 19476605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.